Logo image of MLEC

MOOLEC SCIENCE SA (MLEC) Stock Fundamental Analysis

NASDAQ:MLEC - Nasdaq - LU2559000059 - Common Stock - Currency: USD

2.5  +0.04 (+1.57%)

Fundamental Rating

1

Taking everything into account, MLEC scores 1 out of 10 in our fundamental rating. MLEC was compared to 89 industry peers in the Food Products industry. Both the profitability and financial health of MLEC have multiple concerns. MLEC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MLEC had negative earnings in the past year.
In the past year MLEC has reported a negative cash flow from operations.
In the past 5 years MLEC always reported negative net income.
MLEC had a negative operating cash flow in each of the past 5 years.
MLEC Yearly Net Income VS EBIT VS OCF VS FCFMLEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of MLEC (-237.33%) is worse than 95.51% of its industry peers.
With a Return On Equity value of -600.34%, MLEC is not doing good in the industry: 89.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -237.33%
ROE -600.34%
ROIC N/A
ROA(3y)-73.27%
ROA(5y)N/A
ROE(3y)-207.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MLEC Yearly ROA, ROE, ROICMLEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -100 -200 -300 -400 -500

1.3 Margins

MLEC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLEC Yearly Profit, Operating, Gross MarginsMLEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -1K -2K -3K -4K -5K

More info and screens

1

2. Health

2.1 Basic Checks

MLEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
MLEC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MLEC Yearly Shares OutstandingMLEC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
MLEC Yearly Total Debt VS Total AssetsMLEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -4.07, we must say that MLEC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.07, MLEC is doing worse than 84.27% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that MLEC is not too dependend on debt financing.
MLEC has a Debt to Equity ratio of 0.03. This is in the better half of the industry: MLEC outperforms 78.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -4.07
ROIC/WACCN/A
WACC7.35%
MLEC Yearly LT Debt VS Equity VS FCFMLEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

MLEC has a Current Ratio of 0.26. This is a bad value and indicates that MLEC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.26, MLEC is not doing good in the industry: 95.51% of the companies in the same industry are doing better.
A Quick Ratio of 0.22 indicates that MLEC may have some problems paying its short term obligations.
With a Quick ratio value of 0.22, MLEC is not doing good in the industry: 94.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.22
MLEC Yearly Current Assets VS Current LiabilitesMLEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%948.41%

3.2 Future

The Earnings Per Share is expected to grow by 17.39% on average over the next years. This is quite good.
MLEC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 106.59% yearly.
EPS Next Y86.74%
EPS Next 2Y37.03%
EPS Next 3Y26.42%
EPS Next 5Y17.39%
Revenue Next Year15.44%
Revenue Next 2Y22.5%
Revenue Next 3Y137.77%
Revenue Next 5Y106.59%

3.3 Evolution

MLEC Yearly Revenue VS EstimatesMLEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
MLEC Yearly EPS VS EstimatesMLEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MLEC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MLEC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLEC Price Earnings VS Forward Price EarningsMLEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLEC Per share dataMLEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as MLEC's earnings are expected to grow with 26.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.03%
EPS Next 3Y26.42%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MLEC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOOLEC SCIENCE SA

NASDAQ:MLEC (8/18/2025, 4:44:52 PM)

2.5

+0.04 (+1.57%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-04 2025-08-04
Earnings (Next)09-30 2025-09-30/bmo
Inst Owners0.12%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap28.90M
Analysts82.86
Price Target30.6 (1124%)
Short Float %0.06%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.61%
Min EPS beat(2)1.96%
Max EPS beat(2)73.26%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)900%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-900%
EPS NY rev (1m)0%
EPS NY rev (3m)-900%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.93
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB 92.45
EV/EBITDA N/A
EPS(TTM)-2.2
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS0.23
BVpS0.77
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -237.33%
ROE -600.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.27%
ROA(5y)N/A
ROE(3y)-207.94%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.22
Altman-Z -4.07
F-Score4
WACC7.35%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y86.74%
EPS Next 2Y37.03%
EPS Next 3Y26.42%
EPS Next 5Y17.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%948.41%
Revenue Next Year15.44%
Revenue Next 2Y22.5%
Revenue Next 3Y137.77%
Revenue Next 5Y106.59%
EBIT growth 1Y-189.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.33%
EBIT Next 3Y25.49%
EBIT Next 5Y21.71%
FCF growth 1Y-506.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-498.72%
OCF growth 3YN/A
OCF growth 5YN/A